Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium

OBJECTIVES: In the present study, we explored the real-world efficacy of the immuno-oncology checkpoint inhibitor nivolumab and the tyrosine kinase inhibitor cabozantinib in the second-line setting. METHODS: Using the International Metastatic Renal Cell Carcinoma Database Consortium (imdc) dataset,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Curr Oncol
Main Authors: Stukalin, I., Wells, J.C., Graham, J., Yuasa, T., Beuselinck, B., Kollmansberger, C., Ernst, D.S., Agarwal, N., Le, T., Donskov, F., Hansen, A.R., Bjarnason, G.A., Srinivas, S., Wood, L.A., Alva, A.S., Kanesvaran, R., Fu, S.Y.F., Davis, I.D., Choueiri, T.K., Heng, D.Y.C.
Format: Artigo
Sprog:Inglês
Udgivet: Multimed Inc. 2019
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6476457/
https://ncbi.nlm.nih.gov/pubmed/31043824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4595
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker